Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation.
Cummings SR, Eckert S, Krueger KA, Grady D, Powles TJ, Cauley JA, Norton L, Nickelsen T, Bjarnason NH, Morrow M, Lippman ME, Black D, Glusman JE, Costa A, Jordan VC. Cummings SR, et al. Among authors: bjarnason nh. JAMA. 1999 Jun 16;281(23):2189-97. doi: 10.1001/jama.281.23.2189. JAMA. 1999. PMID: 10376571 Clinical Trial.
Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early postmenopausal women: three-year data from 2 double-blind, randomized, placebo-controlled trials.
Johnston CC Jr, Bjarnason NH, Cohen FJ, Shah A, Lindsay R, Mitlak BH, Huster W, Draper MW, Harper KD, Heath H 3rd, Gennari C, Christiansen C, Arnaud CD, Delmas PD. Johnston CC Jr, et al. Among authors: bjarnason nh. Arch Intern Med. 2000 Dec 11-25;160(22):3444-50. doi: 10.1001/archinte.160.22.3444. Arch Intern Med. 2000. PMID: 11112238 Clinical Trial.
Tibolone: prevention of bone loss in late postmenopausal women.
Bjarnason NH, Bjarnason K, Haarbo J, Rosenquist C, Christiansen C. Bjarnason NH, et al. Among authors: bjarnason k. J Clin Endocrinol Metab. 1996 Jul;81(7):2419-22. doi: 10.1210/jcem.81.7.8675554. J Clin Endocrinol Metab. 1996. PMID: 8675554 Clinical Trial.
Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. Early Postmenopausal Intervention Cohort (EPIC) study group.
Ravn P, Cizza G, Bjarnason NH, Thompson D, Daley M, Wasnich RD, McClung M, Hosking D, Yates AJ, Christiansen C. Ravn P, et al. Among authors: bjarnason nh. J Bone Miner Res. 1999 Sep;14(9):1622-7. doi: 10.1359/jbmr.1999.14.9.1622. J Bone Miner Res. 1999. PMID: 10469292 Free article. Clinical Trial.
65 results